Incremental cost-effectiveness analysis of a multidisciplinary renal education program for patients with chronic renal disease

References

• Eknoyan G, Lameire N, Barsoum R, Eckardt KU, Levin A, Levin N, Locatelli F, MacLeod A, Vanholder R, Walker R, et al The burden of kidney disease: improving global outcomes. Kidney Int 2004;66:1310–1314.
   PubMed Web of Science ®Google Scholar
• Chadban SJ, Briganti EM, Kerr PG, Dunstan DW, Welborn TA, Zimmet PZ, Atkins RC. Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J Am Soc Nephrol 2003;14(7 Suppl 2): S131–S138.
   Google Scholar
• Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003;41:1–12.
   PubMed Web of Science ®Google Scholar
• Ismail N, Neyra R, Hakim R. The medical and economical advantages of early referral of chronic renal failure patients to renal specialists. Nephrol Dial Transplant 1998;13:246–250.
   PubMed Web of Science ®Google Scholar
• Locatelli F, Vecchio LD, Pozzoni P. The importance of early detection of chronic kidney disease. Nephrol Dial Transplant 2002;17 Suppl 11: 2–7.
   PubMed Web of Science ®Google Scholar
• Devins GM, Mendelssohn DC, Barre PE, Binik YM. Predialysis psychoeducational intervention and coping styles influence time to dialysis in chronic kidney disease. Am J Kidney Dis 2003;42:693–703.
   PubMed Web of Science ®Google Scholar
• Devins GM, Mendelssohn DC, Barre PE, Taub K, Binik YM. Predialysis psychoeducational intervention extends survival in CKD: a 20-year follow-up. Am J Kidney Dis 2005;46:1088–1098.
   PubMed Web of Science ®Google Scholar
• Ravani P, Marinangeli G, Tancredi M, Malberti F. Multidisciplinary chronic kidney disease management improves survival on dialysis. J Nephrol 2003;16:870–877.
   PubMed Web of Science ®Google Scholar
• Binik YM, Devins GM, Barre PE, Guttmann RD, Hollomby DJ, Mandin H, Paul LC, Hons RB, Burgess ED. Live and learn: patient education delays the need to initiate renal replacement therapy in end-stage renal disease. J Nerv Ment Dis 1993;181:371–376.
   PubMed Web of Science ®Google Scholar
• Curtis BM, Ravani P, Malberti F, Kennett F, Taylor PA, Djurdjev O, Levin A. The short- and long-term impact of multi-disciplinary clinics in addition to standard nephrology care on patient outcomes. Nephrol Dial Transplant 2005;20:147–154.
   PubMed Web of Science ®Google Scholar
• St Peter WL, Schoolwerth AC, McGowan T, McClellan WM. Chronic kidney disease: issues and establishing programs and clinics for improved patient outcomes. Am J Kidney Dis 2003;41:903–924.
   PubMed Web of Science ®Google Scholar
• Rasgon S, James-Rogers A, Chemleski B, Ledezma M, Mercado L, Besario M, Trivedi J, Miller M, Dee L, Pryor L, et al Maintenance of employment on dialysis. Adv Ren Replace Ther 1997;4:152–159.
   PubMedGoogle Scholar
• Mahlmeister J, Fritschka E. Long-term effects of a new multidisciplinary renal education programme on kidney function and renal risk factors. Nieren-und Hochdruckkrankheiten 2003;32:437–447.
   Google Scholar
• Donadio JV Jr, Larson TS, Bergstralh EJ, Grande JP. A randomized trial of high-dose compared with low-dose omega-3 fatty acids in severe IgA nephropathy. J Am Soc Nephrol 2001;12:791–799.
   PubMed Web of Science ®Google Scholar
• Scholl U, Wastl U, Risler T, Braun N, Grabensee B, Heering P, Schollmeyer P, Zauner I, Stein G, Funfstuck R, et al The “point of no return” and the rate of progression in the natural history of IgA nephritis. Clin Nephrol 1999;52:285–292.
   PubMed Web of Science ®Google Scholar
• Shmuely H, Pitlik S, Drucker M, Samra Z, Konisberger H, Leibovici L. Prediction of mortality in patients with bacteremia: the importance of pre-existing renal insufficiency. Ren Fail 2000;22:99–108.
   PubMed Web of Science ®Google Scholar
• Krauth C, Hessel F, Hansmeier T, Wasem J, Seitz R, Schweikert B. [Empirical standard costs for health economic evaluation in Germany – a proposal by the working group methods in health economic evaluation]. Gesundheitswesen 2005;67:736–746.
   PubMed Web of Science ®Google Scholar
• Kool JP, Oesch PR, Bachmann S, Knuesel O, Dierkes JG, Russo M, de Bie RA, van den Brandt PA. Increasing days at work using function-centered rehabilitation in nonacute nonspecific low back pain: a randomized controlled trial. Arch Phys Med Rehabil 2005;86:857–864.
   PubMed Web of Science ®Google Scholar
• Merkesdal S, Ruof J, Huelsemann JL, Mittendorf T, Handelmann S, Mau W, Zeidler H. Indirect cost assessment in patients with rheumatoid arthritis (RA): comparison of data from the health economic patient questionnaire HEQ-RA and insurance claims data. Arthritis Rheum 2005;53:234–240.
   PubMed Web of Science ®Google Scholar
• Merkesdal S, Ruof J, Schoffski O, Bernitt K, Zeidler H, Mau W. Indirect medical costs in early rheumatoid arthritis: composition of and changes in indirect costs within the first three years of disease. Arthritis Rheum 2001;44:528–534.
   PubMed Web of Science ®Google Scholar
• Barber JA, Thompson SG. Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat Med 2000;19:3219–3236.
   PubMed Web of Science ®Google Scholar
• Carpenter J, Bithell J. Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians. Stat Med 2000;19:1141–1164.
   PubMed Web of Science ®Google Scholar
• Briggs AH, O'Brien BJ, Blackhouse G. Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies. Annu Rev Public Health 2002;23:377–401.
   PubMed Web of Science ®Google Scholar
• Briggs A, Fenn P. Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane. Health Econ 1998;7:723–740.
   PubMed Web of Science ®Google Scholar
• Fenwick E, O'Brien BJ, Briggs A. Cost-effectiveness acceptability curves – facts, fallacies and frequently asked questions. Health Econ 2004;13:405–415.
   PubMed Web of Science ®Google Scholar
• Drummond MF, O'Brien B, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. 2nd ed. New York: Oxford Medical Publications; 1997.
   Google Scholar
• Briggs AH. Statistical approaches to handling uncertainty in health economic evaluation. Eur J Gastroenterol Hepatol 2004;16:551–561.
   PubMed Web of Science ®Google Scholar
• Singer J, Willet J. Applied longitudinal data analysis. New York: Oxford University Press; 2003.
   Google Scholar
• Levin A, Lewis M, Mortiboy P, Faber S, Hare I, Porter EC, Mendelssohn DC. Multidisciplinary predialysis programs: quantification and limitations of their impact on patient outcomes in two Canadian settings. Am J Kidney Dis 1997;29:533–540.
   PubMed Web of Science ®Google Scholar
• Knapp M, Thorgrimsen L, Patel A, Spector A, Hallam A, Woods B, Orrell M. Cognitive stimulation therapy for people with dementia: cost-effectiveness analysis. Br J Psychiatry 2006;188:574–580.
   PubMed Web of Science ®Google Scholar
• Briggs A. Economic evaluation and clinical trials: size matters. BMJ 2000;321:1362–1363.
   PubMed Web of Science ®Google Scholar